{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T09:32:57Z","timestamp":1775208777487,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T00:00:00Z","timestamp":1547856000000},"content-version":"vor","delay-in-days":1448,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.repc.2014.08.021","type":"journal-article","created":{"date-parts":[[2015,2,3]],"date-time":"2015-02-03T17:15:17Z","timestamp":1422983717000},"page":"111-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry"],"prefix":"10.1016","volume":"34","author":[{"given":"Oleg","family":"Gaisenok","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Martsevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Tripkosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulia","family":"Lukina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.repc.2014.08.021_bib0085","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.repc.2014.08.021_bib0090","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1016\/j.repc.2014.08.021_bib0095","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/01.CIR.99.2.216","article-title":"Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study","volume":"99","author":"Plehn","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.repc.2014.08.021_bib0100","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2014.08.021_bib0105","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(96)04292-4","article-title":"West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2014.08.021_bib0110","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.repc.2014.08.021_bib0115","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2014.08.021_bib0120","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","article-title":"Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey","volume":"378","author":"Yusuf","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.repc.2014.08.021_bib0125","first-page":"324","article-title":"Main results of the Moscow Research on Statines (to Moscow Statin Survey, MSS)","author":"Susekov","year":"2006","journal-title":"Serdce"},{"key":"10.1016\/j.repc.2014.08.021_bib0130","first-page":"4","article-title":"Using registers to study effectiveness and safety of drugs","volume":"3\u20134","author":"Martsevich","year":"2012","journal-title":"Clinician"},{"key":"10.1016\/j.repc.2014.08.021_bib0135","doi-asserted-by":"crossref","first-page":"681","DOI":"10.20996\/1819-6446-2012-8-5-681-684","article-title":"The LIS study (Lubertsy study of mortality in patients with acute myocardial infarction). Evaluation of pharmacotherapy. Part 1. Treatment of patients before myocardial infarction and its influence on hospital mortality","volume":"8","author":"Martsevich","year":"2012","journal-title":"Rational Pharmacother Card"},{"key":"10.1016\/j.repc.2014.08.021_bib0140","first-page":"1408","article-title":"Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study","volume":"29","author":"Ivers","year":"2013","journal-title":"Can J Cardiol"},{"issue":"Suppl 2","key":"10.1016\/j.repc.2014.08.021_bib0145","doi-asserted-by":"crossref","first-page":"S529","DOI":"10.1007\/s11606-013-2340-5","article-title":"Accounting for clinical action reduces estimates of gender disparities in lipid management for diabetic veterans","volume":"28","author":"Vimalananda","year":"2013","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.repc.2014.08.021_bib0150","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjmed.2013.01.033","article-title":"Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis; REduction of Atherothrombosis for Continued Health Registry Investigators","volume":"126","author":"Kumbhani","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.repc.2014.08.021_bib0155","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/pds.3526","article-title":"Factors influencing adherence in long-term use of statins","volume":"22","author":"Warren","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.repc.2014.08.021_bib0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jacl.2013.10.002","article-title":"Use of health information technology (HIT) to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients: proceedings from a workshop","volume":"7","author":"Cohen","year":"2013","journal-title":"J Clin Lipidol"}],"container-title":["Revista Portuguesa de Cardiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255115000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0870255115000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:02:19Z","timestamp":1760108539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0870255115000062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0870255115000062"],"URL":"https:\/\/doi.org\/10.1016\/j.repc.2014.08.021","relation":{},"ISSN":["0870-2551"],"issn-type":[{"value":"0870-2551","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2014.08.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}